|
|
|
Insider
Information: |
Schuth Alexander O. |
Relationship: |
COFO and Secretary |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
178,066 |
|
Indirect Shares
|
523,749 |
|
|
Direct
Value |
$5,398,961 |
|
|
Indirect Value
|
$15,880,070 |
|
|
Total
Shares |
701,815 |
|
|
Total
Value |
$21,279,031 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
9
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
9
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-9.0
|
Percentage
Gain/Loss : |
0.0%
|
-393.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Denali Therapeutics Inc. |
DNLI |
COFO and Secretary |
2024-08-21 |
178,066 |
2024-08-21 |
523,749 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2021-08-19 |
4 |
S |
$49.56 |
$126,186 |
I/I |
(2,544) |
484,038 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2021-09-07 |
4 |
AS |
$54.70 |
$555,485 |
I/I |
(10,000) |
474,038 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2021-09-20 |
4 |
OE |
$0.68 |
$6,151 |
D/D |
9,045 |
95,499 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2021-10-04 |
4 |
AS |
$50.24 |
$505,605 |
I/I |
(10,000) |
473,083 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2021-11-04 |
4 |
AS |
$52.65 |
$528,404 |
I/I |
(10,000) |
463,083 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2021-12-06 |
4 |
AS |
$41.82 |
$422,736 |
I/I |
(10,000) |
453,083 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
31,000 |
117,454 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2022-01-05 |
4 |
S |
$44.77 |
$127,415 |
I/I |
(2,846) |
457,737 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2022-02-09 |
4 |
S |
$37.10 |
$52,800 |
I/I |
(1,423) |
460,564 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2022-02-11 |
4 |
S |
$34.68 |
$97,208 |
I/I |
(2,803) |
465,047 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2022-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
121,458 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2022-08-19 |
4 |
S |
$33.22 |
$85,575 |
I/I |
(2,576) |
467,471 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2022-10-07 |
4 |
OE |
$0.68 |
$13,600 |
I/I |
20,000 |
487,471 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
41,120 |
157,578 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-01-04 |
4 |
S |
$28.70 |
$83,574 |
D/D |
(2,912) |
149,828 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-01-04 |
4/A |
S |
$28.70 |
$83,574 |
I/I |
(2,912) |
492,309 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-01-05 |
4 |
S |
$28.44 |
$74,968 |
I/I |
(2,636) |
497,173 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-01-17 |
4 |
OE |
$5.28 |
$52,800 |
I/I |
10,000 |
507,173 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-01-17 |
4 |
AS |
$29.53 |
$295,339 |
I/I |
(10,000) |
497,173 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-02-08 |
4 |
S |
$30.89 |
$46,984 |
I/I |
(1,521) |
499,902 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-02-13 |
4 |
S |
$30.09 |
$105,225 |
I/I |
(3,497) |
528,691 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-02-13 |
4 |
OE |
$0.68 |
$17,000 |
I/I |
25,000 |
524,902 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-04-12 |
4 |
OE |
$5.28 |
$26,939 |
I/I |
5,102 |
533,793 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-04-12 |
4 |
AS |
$25.04 |
$127,754 |
I/I |
(5,102) |
528,691 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-04-13 |
4 |
OE |
$5.28 |
$25,861 |
I/I |
4,898 |
533,589 |
0 |
- |
|
93 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|